Viewing data from:

MONO-LINYAH

ANDA

ETHINYL ESTRADIOL; NORGESTIMATE | A090523 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Mono-Linyah (2023)

Total Spending

$84K

Total Claims

3,521

Beneficiaries

826

Avg Cost/Unit

$0.50

Spending Trend

$161K(2019)→$182K(2020)→$155K(2021)→$109K(2022)→$84K(2023)

YoY Change:-8.6%

5yr CAGR:+2.8%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.035MG;0.25MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: May 23, 2012

No patent or exclusivity listings for this strength.